Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Sato

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|May 2, 2025
Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective StudyFumiya Yoneyama, Masanao Shinohara, Yohei Kawashima, et al.
Urologic Oncology|May 14, 2026
Presenting postoperative mortality as percentages and natural frequencies (1-in-N) in major urologic cancer surgeriesIzuki Ogawa, Masanao Shinohara, Naoki Fujita, et al.
ACS Omega|August 29, 2019
In Situ Spectroscopic and Computational Studies on a MnO<sub>2</sub>-CuO Catalyst for Use in Volatile Organic Compound DecompositionJungpil Kim, Young Hwan Min, Nodo Lee, et al.
Journal of Clinical Biochemistry and Nutrition|April 3, 2019
Influence of gastric endoscopic submucosal dissection on serum opsonic activity measured by chemiluminescenceTetsu Arai, Daisuke Chinda, Tadashi Shimoyama, et al.
European Urology Open Science|May 21, 2026
Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical SurgeryShunsuke Tazawa, Masanao Shinohara, Yohei Kawashima, et al.
Cancer Medicine|July 5, 2023
Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinomaKazuyuki Numakura, Yuya Sekine, Shingo Hatakeyama, et al.
Urologic Oncology|June 15, 2026
Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world studyKeita Ishimoto, Takuma Narita, Yuya Sekine, et al.
International Journal of Clinical Oncology|September 14, 2025
Cross-resistance among novel androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancerTakuya Oishi, Naoki Fujita, Yohei Kawashima, et al.
International Journal of Clinical Oncology|July 7, 2025
Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective studyFumiya Yoneyama, Naoki Fujita, Yohei Kawashima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 4, 2025
Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter StudyKai Ozaki, Hayato Yamamoto, Yuya Sekine, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
International Journal of Urology : Official Journal of the Japanese Urological Association|May 2, 2025
Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective StudyFumiya Yoneyama, Masanao Shinohara, Yohei Kawashima, et al.
Urologic Oncology|May 14, 2026
Presenting postoperative mortality as percentages and natural frequencies (1-in-N) in major urologic cancer surgeriesIzuki Ogawa, Masanao Shinohara, Naoki Fujita, et al.
ACS Omega|August 29, 2019
In Situ Spectroscopic and Computational Studies on a MnO<sub>2</sub>-CuO Catalyst for Use in Volatile Organic Compound DecompositionJungpil Kim, Young Hwan Min, Nodo Lee, et al.
Journal of Clinical Biochemistry and Nutrition|April 3, 2019
Influence of gastric endoscopic submucosal dissection on serum opsonic activity measured by chemiluminescenceTetsu Arai, Daisuke Chinda, Tadashi Shimoyama, et al.
European Urology Open Science|May 21, 2026
Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical SurgeryShunsuke Tazawa, Masanao Shinohara, Yohei Kawashima, et al.
Cancer Medicine|July 5, 2023
Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinomaKazuyuki Numakura, Yuya Sekine, Shingo Hatakeyama, et al.
Urologic Oncology|June 15, 2026
Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world studyKeita Ishimoto, Takuma Narita, Yuya Sekine, et al.
International Journal of Clinical Oncology|September 14, 2025
Cross-resistance among novel androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancerTakuya Oishi, Naoki Fujita, Yohei Kawashima, et al.
International Journal of Clinical Oncology|July 7, 2025
Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective studyFumiya Yoneyama, Naoki Fujita, Yohei Kawashima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 4, 2025
Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter StudyKai Ozaki, Hayato Yamamoto, Yuya Sekine, et al.
Pageof 17